The survivin gene expression in neoplastic hepatocytes from chickens infected with Marek’s virus

PDF (English)
DOI: https://doi.org/10.12681/jhvms.20828
Λέξεις-κλειδιά:
Chicken Gene expression Marek’s disease Survivin
R. NASIRI
Department of Biology, Science and Research Branch, Islamic Azad University
M. GHOLAMI-AHANGARAN
Department of Poultry Diseases, Veterinary Medicine Faculty, Shahrekord Branch, Islamic Azad University
P. EBADI
Department of Biology, Science and Research Branch, Islamic Azad University
Περίληψη
ΔΕΝ ΔΙΑΤΙΘΕΤΑΙ ΠΕΡΙΛΗΨΗ
Λεπτομέρειες άρθρου
  • Ενότητα
  • Research Articles
Creative Commons License

Αυτή η εργασία είναι αδειοδοτημένη υπό το CC Αναφορά Δημιουργού – Μη Εμπορική Χρήση 4.0.

Οι συγγραφείς των άρθρων που δημοσιεύονται στο περιοδικό διατηρούν τα δικαιώματα πνευματικής ιδιοκτησίας επί των άρθρων τους, δίνοντας στο περιοδικό το δικαίωμα της πρώτης δημοσίευσης.

Άρθρα που δημοσιεύονται στο περιοδικό διατίθενται με άδεια Creative Commons 4.0 Non Commercial και σύμφωνα με την άδεια μπορούν να χρησιμοποιούνται ελεύθερα, με αναφορά στο/στη συγγραφέα και στην πρώτη δημοσίευση για μη κερδοσκοπικούς σκοπούς.

Οι συγγραφείς μπορούν να καταθέσουν το άρθρο σε ιδρυματικό ή άλλο αποθετήριο ή/και να το δημοσιεύσουν σε άλλη έκδοση, με υποχρεωτική την αναφορά πρώτης δημοσίευσης στο J Hellenic Vet Med Soc

Οι συγγραφείς ενθαρρύνονται να καταθέσουν σε αποθετήριο ή να δημοσιεύσουν την εργασία τους στο διαδίκτυο πριν ή κατά τη διαδικασία υποβολής και αξιολόγησής της.

Λήψεις
Τα δεδομένα λήψης δεν είναι ακόμη διαθέσιμα.
Αναφορές
Altieri DC, Marchisio C (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327–1333.
Altieri DC (2015) Survivin-the inconvenient IAP. Semin Cell Dev Biol 39: 91-96.
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene survivin expressed in cancer and lymphoma. Nat Med 3: 917–921.
Johnson ME, Howerth EW (2004) Survivin: A Bifunctional Inhibitor of Apoptosis Protein Vet Pathol 41: 599-607.
Bancroft JD, Stevens A (1996) Theory and practice of histopathological techniques. Churchill livingstone: London: 100-110.
Becker Y, Asher Y, Tabor E, Davidson I, Malkinson M, Weisman Y (1992) Polymerase chain reaction for differentiation between pathogenic and nonpathogenic serotype 1 Marek’s disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3 J Virol Methods 40: 307-322.
Berendse M, Grounds MD, Lioyd CM (2003) Myoblast structure affects subsequent skeletal myotube morphology and sarcomere assembly Exp Cell Res 291: 435-450.
Biggs PM (2001) The history and biology of Marek disease virus Curr Top Microbiol Immunol 255:1-24.
Borbely AA, Murvai M, Konya J, Beck Z, Gergely L, Li F (2006) Effect of human papillomavirus type 16 oncoproteins on survivin gene expression J Gen Virol 87: 287–294.
Calnek BW (2001) Pathogenesis of Marek disease virus infection Curr Top Microbiol Immunol 255:25-55.
Chen JC, Goldhamer DJ (2003) Skeletal muscle stem cells Reported boil Endocrinol 1: 101-107.
Fan Y, Liu Z, Zhao S, Lou F, Nilsson S, Ekman P (2006) Nucleostemin mRNA is expressed in both normal and malignant renal tissues Brit J Cancer 94: 1658-62.
Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression of the apoptosis inhibitor survivin in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line Lab Invest 79: 1121–1126.
Hino R, Uozaki H, Inoue Y, Shintani Y, Ushiku T, Sakatani T (2008) Survival advantage of EBV-associated gastric carcinoma: surviving up-regulation by viral latent membrane protein 2A. Cancer Res. 68:1427–1435.
Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatol 31: 1080-1085.
Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T( 2001) Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95.
Kawakami H, Tomita M, Matsuda T, Ohta T, Tanaka Y, Fujii M, Hatano M, Tokuhisa T, Mori N (2005) Transcriptional activation of surviving through the NF-kappaB pathway by human T-cell leukemia virus type I tax. Int J Cancer 115: 967-974.
Kozdrun W, Samorek-Salamonowicz E, Czekay H (2001) PCR for the differentiation of Marek’s disease virus strain. Bull Vet Inst Pulway 45: 5-10.
Lei Y, Geng Z, Guo-Jun W, He W, Jian-Lin Y (2010) Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance. Mol Cell Biochem 344: 23-31.
Li YP, Bang DD, Handberg KJ, Jorgensen PH, Zhang MF (2005) Evaluation of the suitability of six host genes as internal control in real-time RT-PCR assays in chicken embryo cell cultures infected with infectious bursal disease virus. Vet Mic 110: 155-165.
Marek J (1907) Multiple Nervenentzuendung (Polynephritis) bei ituehnern Dtsch Tiemztl Wochenschr 15:417-421.
Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22: 2729-2740.
Nachmias B, Ashhab Y, Ben-Yehud D (2004) The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 14: 231-243.
Nair V, Kung HJ (2004) Marek’s disease virus oncogenicity: molecular mechanisms. In: Marek’s Disease. Academic Press, New York: 32-48.
Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60: 2805-2809.
Saitoh Y, Yaginuma Y, Ishikawa M (1999) Analysis of Bcl-2 Bax and surviving genes in uterine cancer. Int J Oncol 15: 137–141.
Schat KA, Nair V (2013) Marek’s disease In: Disease of Poultry, 13th ed, Wiley-Blackwell, Massachusetts: 515-565.
Shahzad MK, Majeed KA, Younus M (2007) Marek’s Disease: A Mini-Review. Int J Agro Vet Med Sci 1: 4-8.
Shaikh Z, Niranjan KC (2015) Tumour biology: p53 gene mechanisms. JClin Cell Immunol 6: 12-18.
Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC (1999) Tumor content of the antiapoptosis molecule surviving and recurrence of bladder cancer. N Eng J Med 341: 452–453.
Tamm I, Kornblau SM, Segall H (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796- 803.
Tulman ER, Afonso CL, Lu Z, Zsak L, Rock DL, Kutish GF (2000) The genome of a very virulent Marek disease virus J Virol 74:7980-7988.
Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP (2000) Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 7: 602-608.
Yoshida H, Ishiko O, Sumi T, Matsumoto Y, Ogita S (2001) Survivin bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 19: 537-542.
Zhao Y, Kurian D, Xu H, Petherbridge L, Smith LP, Hunt L (2009) Interaction of Marek’s disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells. J Gen Virol 90: 2201–2208.
Zhu GS, Ojima T, Hironaka T, Ihara T, Mizukoshi N, Kato A (1992) Differentiation of oncogenic and non-oncogenic strains of MDV type 1 by PCR DNA amplification. Avian Dis 36: 637-645.